Home platform-guided nursing improves functional and psychological outcomes after lung cancer surgery in small trial
In a randomized controlled trial at Yichang Central People's Hospital, 50 patients after lung cancer surgery were assigned to receive either standard care or standard care plus Internet + nursing services via a home intelligent management platform (HIM)-guided personalized nursing. The intervention was delivered post-discharge, with outcomes assessed at follow-up. The primary outcome was not explicitly distinguished from secondary outcomes in the reported text.
The HIM group showed superior results compared to the control group for several outcomes, including 6-minute walk test (6MWT) distance, functional domains, overall health status, and greater reductions in Borg Scale, Visual Analog Scale (VAS), Self-Rating Anxiety/Depression Scales (SAS/SDS), pain, and dyspnea scores (all P < 0.05). Significant within-group improvements in these measures were also observed in both groups (P < 0.05). Exact numerical data, effect sizes, and absolute numbers for these comparisons were not reported.
Safety and tolerability data, including adverse events and discontinuations, were not reported. Key limitations include the small sample size (n=50), single-center setting, lack of reported safety data, and absence of detailed numerical results or effect sizes. Funding and conflicts of interest were also not reported. The study suggests a potential role for technology-facilitated home-based rehabilitation, but its findings are preliminary and require validation in larger, more rigorous trials with comprehensive safety monitoring and detailed outcome reporting before clinical application can be considered.